TerrAscend Announces Record Revenue for the First Quarter of 2019 First quarter revenue of $14.6 million, up from $5.0 million in the fourth quarter of 2018 Company reiterates 2019 full-year guidance of...
TerrAscend Announces Books Closed on Over-Subscribed US$52 Million Private Placement TORONTO, May 7, 2019 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) has successfully completed the book-build for...
TerrAscend to be the First and Only Cannabis Company with Sales in the US, Canada, and Europe TerrAscend Canada receives EU GMP certification, announces distribution agreement with German partner Will...
TerrAscend Announces Upsizing of Previously Announced Non-Brokered Private Placement Deal size is increased from previously announced US$30-$40 million due to strong investor demand TORONTO, April 26, 2019 /CNW/ –...
TerrAscend Announces Fourth Quarter 2018 Financial Results Company reiterates previously issued guidance anticipating 2019 full year revenue exceeding $135 million.1 TORONTO, April 24, 2019 /PRNewswire/ – TerrAscend Corp. (CSE:TEROTCQX: TRSSF) (“TerrAscend” or the “Company”)...
TerrAscend Announces Proposed US$20 million -US $30 million Non-Brokered Private Placement TORONTO, April 22, 2019 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) today announced that the Company...
TerrAscend Issues First-Time Full Year 2019 Revenue Guidance TORONTO, April 15, 2019 /PRNewswire/ – TerrAscend Corp. (CSE: TER;OTCQX: TRSSF) (“TerrAscend” or “the Company”) today announced that it anticipates 2019...
TerrAscend Provides Business Update Including Preliminary Fourth Quarter Revenue –4th Quarter revenue increased to CAD$4.8 millioni— –Awarded the right to a vertically-integrated license in New Jersey– –Completed the acquisition of Grander Distribution––Entered...
TerrAscend Establishes US Retail Footprint ANNOUNCES SIGNING OF SECURITIES PURCHASE AGREEMENTS WITH THE APOTHECARIUM All of The Apothecarium team members will continue in their current roles and join TerrAscend’s...
MediPharm Labs Signs Large Multi-Year Cannabis Extraction Agreement With TerrAscend Marking Strong Start to 2019 TORONTO, Jan. 08, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS; OTCQB: MLCPF)...
TORONTO, Dec. 24, 2018 /PRNewswire/ – TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) today announced the signing of a definitive agreement (the “Agreement”) to acquire substantially all of the...
TerrAscend Controlled Entity Awarded One of Six Permits to Apply For Vertically Integrated Licenses in New Jersey Permit to apply for cannabis cultivation, processing and retail operations in populous...
TerrAscend Announces Agreement for US$75 Million Credit Facility – Credit facility to support initiation of TerrAscend’s US acquisition strategy – TORONTO, Dec. 14, 2018 /PRNewswire/ – TerrAscend Corp. (CSE: TER; OTCQX:...
TerrAscend Announces Third Quarter 2018 Financial Results –Revenue increased to $1.8 million– –Haven St. brand successfully launched into Canadian adult-use market– –Announced intention to explore and pursue U.S. growth...
TerrAscend to Enter US Cannabis Market Canopy Growth, Canopy Rivers and JW Asset Management support TerrAscend’s related capital reorganization Jeffrey J. Puglisi appointed Chief Corporate Officer overseeing US Strategy...
TerrAscend’s Wholly-Owned Subsidiary, Solace Health Network Inc., Announces Agreement with MCI Medical Clinics Inc. to Bring Medical Cannabis Expertise to Patients TORONTO, Sept. 20, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) today...
TORONTO, June 18, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to provide an update on its leadership team as the Company continues to...
TerrAscend and Cistron Launch Ascendant Laboratories TORONTO, June 7, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce the formation of a strategic...
TORONTO, May 28, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) today reported financial results for the first quarter ending March 31, 2018. Financial results and the management discussion and analysis are available on...
TerrAscend Provides Strategic Capital to Think AHLOT Corporation, a Leading Cannabis Innovation Company TORONTO, May 1, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) is pleased to announce that the Company has made...
TORONTO, April 26, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) today reported financial results for the fourth quarter and financial year ending December 31, 2017....
TerrAscend Completes Strategic Investment into Fire & Flower TORONTO, April 23, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) is pleased to announce that it has completed...
TerrAscend’s Wholly-Owned Subsidiary, Solace Health Inc., Receives Sales Licence to Sell Dried Cannabis TORONTO, March 9, 2018 /CNW/ – TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”) is pleased to...
TerrAscend Corp provides update on sales licence application TORONTO, March 9, 2018 /CNW/ – At the request of IIROC and as a result of the recent increase in market activity, TerrAscend Corp....
TORONTO, Feb. 5, 2018 /CNW/ – TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. (“Solace”), has been granted an oil production license...
